Document is current
Any future updates will be listed below
-
Authors
Vo, Phuc Leo H. https://orcid.org/0000-0002-3719-7770
Ronda, Carlotta
Klompe, Sanne E. https://orcid.org/0000-0002-0151-9459
Chen, Ethan E. https://orcid.org/0000-0003-1765-8290
Acree, Christopher https://orcid.org/0000-0002-3958-1055
Wang, Harris H.
Sternberg, Samuel H. https://orcid.org/0000-0001-8240-9114
-
Funding
Funding for this research was provided by:
Simons Society of Fellows
National Science Foundation (MCB-1453219)
Burroughs Wellcome Fund (PATH1016691)
Columbia University Irving Medical Center Dean’s Office and the Vagelos Precision Medicine Fund
- License Information
-
More Information
Article History
Received: 24 March 2020
Revised: 19 October 2020
Accepted: 20 October 2020
First Online: 23 November 2020
Competing interests
: P.L.H.V., S.E.K. and S.H.S. are inventors on patents and patent applications related to CRISPR–Cas systems and uses thereof. H.H.W. is a scientific advisor to SNIPR Biome. S.H.S. is a co-founder and scientific advisor to Dahlia Biosciences and an equity holder in Dahlia Biosciences and Caribou Biosciences.
